latest news

News

OIS Retina@ASRS Brings Retina Leaders Together (Again) for Live Meeting in San Antonio

Keith Croes / September 22, 2021
Devices and Diagnostics / OIS Podcast

Revolutionizing Cataract Surgery from Innovation to Commercialization

News / Pharma

Despite Mixed Trial Results and Stock Plunge, Apellis Keeps Commitment to Lead Candidate Pegcetacoplan

OIS Podcast / Pharma

From Big Pharma Lawyer to Eye Care Disruptor: IACTA Pharmaceuticals Founder & CEO Damon Burrows

Devices and Diagnostics / News

Judy Gordon’s Legacy: Helping Firms Navigate a Path to FDA Approval of Transformative Technology

Pharmaceuticals & Genetics

Despite Mixed Trial Results and Stock Plunge, Apellis Keeps Commitment to Lead Candidate Pegcetacoplan

September 15, 2021

From Big Pharma Lawyer to Eye Care Disruptor: IACTA Pharmaceuticals Founder & CEO Damon Burrows

September 15, 2021

NIH Awards Amydis $3 Million Grant Award for Novel Amyloid Beta Retinal Tracer Applicable to CNS Diseases

August 10, 2021

Stem Cell-Engineered Implant for Geographic Atrophy Shows Promise, Long-Term Survival of Cells in Early Trial

August 3, 2021

Apellis Building on Its Platform with APL-2 for Geographic Atrophy

June 8, 2021

The Four Trends Driving the Digital Space

May 25, 2021

devices & diagnostics

Revolutionizing Cataract Surgery from Innovation to Commercialization

September 22, 2021
OIS Summit FDA Approved (2)

Judy Gordon’s Legacy: Helping Firms Navigate a Path to FDA Approval of Transformative Technology

September 7, 2021
Bausch + Lomb

OSD Pipeline Update: Etiology-Specific Treatments for MGD, Demodex Getting Closer

August 31, 2021

Drug Developers Show Renewed Interest in Ocular Allergies

August 24, 2021
Pierre Billardon

Leading a Global Leader, with Pierre Billardon

August 24, 2021

Subscribe To OIS News

Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.
!
!
!
Subscribe

We respect your privacy and will never send you spam.

Something went wrong. Please check your entries and try again.

Listen To The Podcast

Pod 298 - Gary Wortz - Thumbnail (2)

Revolutionizing Cataract Surgery from Innovation to Commercialization

September 22, 2021
Devices and Diagnostics / OIS Podcast
Pod 297 - Damon Burrows - Thumbnail

From Big Pharma Lawyer to Eye Care Disruptor: IACTA Pharmaceuticals Founder & CEO Damon Burrows

September 15, 2021
OIS Podcast / Pharma
Podcast 296 - Jean-Frédéric Chibret - Thumbnail

Leading a Young Company with a Five-Generation History, with Jean-Frédéric Chibret

September 7, 2021
OIS Podcast
Podcast #295 OIS Israel Case Studies - Thumbnail 2

Intimate Discussions from OIS Israel Innovation Showcase

September 1, 2021
OIS Podcast / Uncategorized
Pierre Billardon

Leading a Global Leader, with Pierre Billardon

August 24, 2021
Devices and Diagnostics / News / OIS Podcast
Donald Korb thumbnail

Living the Dream with Donald Korb, OD

August 18, 2021
OIS Podcast / Uncategorized

Deals

4DTM Goes It Alone After Roche Pulls Out of Gene Therapy Trials

July 20, 2021

Samsung Bioepis Brings Heat to Race for Anti-VEGF Biosimilars

July 6, 2021
OIS Index Q2

OIS Index Rallies Back from COVID-Driven Decline

July 9, 2020
With Amblyotech Buy, Novartis Makes a Transformation to the Ophthalmic Device Arena

With Amblyotech Buy, Novartis Makes a Transformation to the Ophthalmic Device Arena

June 10, 2020
AbbVie’s Big Bet to Diversify with Allergan Pays Off So Far

AbbVie’s Big Bet to Diversify with Allergan Pays Off So Far

May 20, 2020

watch videos from ois tv

OIS Index

OIS Index Rallies Back from COVID-Driven Decline

OIS Index Posts a Strong Finish to 2019

OIS Index Outperforms

OIS Index on Positive Upswing

OIS Index Deep in Bear Territory in Q3

OIS Index Posts Modest Gain for Q2; Ophthalmic Market Leader Alcon Joins Index

OIS Index Delivers Stellar First-Quarter 2019 Performance